Produit
AGENTS IA
APPLICATIONS DE L'IA
AUTRES
Solutions
SECTEURS D'ACTIVITÉ
Tarification
Ressources
EXPLORER
ENGAGER
ASSISTANCE ET SERVICES
À propos
Plateforme PatSnap Eureka
Mandataires en propriété intellectuelle
Agents pour l'ingénierie
Agents pour les sciences de la vie
Agents pour matériaux
Analytique
Intelligence IPSynapse
Renseignement biopharmaceutiqueBiographie
Recherche et analyse de séquences biologiquesChimique
Recherche et analyse de structures chimiquesPlateforme ouverte
Services professionnels
Témoignages clients
Newsroom
Blog
Rapport mondial sur l'innovation
Glossaire
Webinaires et formations
Frontière
Communauté d'utilisateurs
Confiance et sécurité
PatentBench
LLM
Centre d'aide
Carrières
Accès à plus de 2 000 000 000 points de données structurées dans les domaines des brevets, des sciences, des litiges et des technologies.
Innovez 75 % plus vite à un coût réduit de 25 %.
Cloud ou sur site pour une confidentialité et un contrôle maximaux
Reconnu par plus de 18 000 innovateurs à travers le monde
Pour l'utiliser, cliquez sur le bouton de vérification dans l'e-mail que nous avons envoyé à [email protected].
Cela contribue à sécuriser votre compte.
Vous devriez le recevoir sous peu. N'oubliez pas de vérifier votre dossier spam.
Unlock professional features and history
Already have an account? Log In
To start using PatSnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Série soigneusement sélectionnée offrant des informations précieuses aux professionnels de l'innovation.
Article | Rapport How AI-powered process optimization is transforming energy consumption management in continuous chemical manufacturing — key approaches, research directions, and innovation intelligence.
Article | Rapport Mapping the 2026 lipidomics profiling landscape: LC-HRMS, ion mobility, computational tools, clinical standardization, and emerging directions across 15+ countries.
Article | Rapport COMP360 psilocybin enters Phase III for treatment-resistant depression as MindMed's MM-120 advances in GAD. Analyse the readout race, trial design, and IP landscape.
Article | Rapport What are the main technical challenges of integrating neuromorphic computing chips into real-time robotic perception systems? A deep-dive for R&D and IP teams.
Article | Rapport Explore the graphene oxide functionalization landscape in 2026: patent strategies, application domains, and how R&D teams can build a rigorous GO intelligence pipeline.
Article | Rapport How Roche's trontinemab GRADUATE-3 Phase II trial compares to Kisunla and Leqembi: subcutaneous monthly dosing, TfR1 brain shuttle, and ARIA safety signals explained.
Article | Rapport Explore the key engineering differences between static and dynamic seal design in high-pressure cryogenic fluid systems — covering materials, leakage, and thermal cycling.
Article | Rapport Explore the 2026 technology landscape for biomass-derived carbon materials — biochar, activated carbon, hydrochar — and how PatSnap Eureka maps innovation.
Article | Rapport Mapping the 2026 continuous ketone monitor patent landscape: dual-analyte biosensors, breath acetone sensing, and wearable metabolic platforms reshaping diabetes care.
Article | Rapport Etavopivat (FT-4202) activates pyruvate kinase R to induce fetal hemoglobin without genome editing. Explore Phase 2/3 PEARL trial data and Novo Nordisk's IP strategy.
Article | Rapport Explore the 2026 landscape of CO₂ electroreduction catalyst materials: copper catalysts, SACs, MOFs, and key IP trends shaping carbon utilisation technology.
Article | Rapport No source data was provided for this topic. This page explains why the article cannot be produced and what steps are needed to generate a fully evidenced report.
Article | Rapport A 56-year patent and literature landscape of RLV heat shield technology: active cooling, deployable shields, ablative TPS, and emerging IP frontiers for 2026.
Article | Rapport Model predictive control vs reinforcement learning for industrial process optimization: key technical differences, trade-offs, and when to use each strategy.
Article | Rapport SGLT2 inhibitors empagliflozin and dapagliflozin are reshaping cardiorenal medicine. Explore the Phase III landscape, competitive IP signals, and what to do when data pipelines fail.